Role of sublingual asenapine in treatment of schizophrenia
Leslie CitromeNew York University School of Medicine, Department of Psychiatry, New York, NY, USAAbstract: Asenapine tablets are a new option for the treatment of schizophrenia. Sublingual administration is essential because bioavailability if ingested is less than 2%. Efficacy is supported by acute...
Guardado en:
Autor principal: | Citrome L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/589f49acb84f4d5fa42f9e3e44a0e5f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
por: Warren CG, et al.
Publicado: (2013) -
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
por: Delia Bishara, et al.
Publicado: (2009) -
The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
por: Pompili M, et al.
Publicado: (2011) -
Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao K, et al.
Publicado: (2013) -
Role of aripiprazole in treatment-resistant schizophrenia
por: Mossaheb N, et al.
Publicado: (2012)